Try our Advanced Search for more refined results
Searching dockets in Fresenius Se Co Kgaa x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability | Puerto Rico
Status Conference ~Util - Set Deadlines/Hearings 1 - Terminate Deadlines
Minute Entry for proceedings held before US Magistrate Judge Hector L. Ramos-Vega: Further Status Conference held on 9/15/2026. Answer deadline due by 10/13/2026 (as to Nefrlogos Asociados del Oeste, CRL; Further Status Conference set for 9/29/2026 at 04:00 PM in VTC Bridge HRV before US Magistrate Judge Hector L. Ramos-Vega. Hearing access credentials are available in the following URL link: https://www.prd.uscourts.gov/video-teleconference-vtc-hearing-links (Court Reporter N/A.) (Hearing held in HRV Virtual Chambers.) Hearing set for 11:00. Hearing held at 11:06. Hearing ended at 11:21. (Ramos-Vega, Hector)
P.I.: Other | Ohio Northern
Order
Reply in support of 6648 Motion by Third Party Payor Plaintiffs' for (1) Final Approval of Class Action Settlement with Allergan, Janssen, Teva, and Settling Pharmacies; and (2) Award of Attorneys' Fees and Expenses and Settlement Class Representative Service filed by Plaintiff Counsel. (Dearman, Mark)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.